Drimmer-Fischler Family Stem Cell Core Laboratory for Regenerative Medicine
Our Research Center
The iPSC Differentiation Center is housed within the Drimmer-Fischler Family Stem Cell Core Laboratory for Regenerative Medicine at Tel Aviv University. Our multidisciplinary team comprises leading researchers in biomedical engineering, neurobiology, and regenerative medicine, working collaboratively to develop innovative solutions in stem cell research. Our core team includes:
​
-
Prof. Uri Ashery and Prof. Ben M. Maoz – Principal investigators leading cross-disciplinary research in iPSC applications – Founders
-
Dr. Yakey Yaffe – Leading Scientist of the Drimmer-Fischler Family Stem Cell Core Laboratory for Regenerative Medicine
-
Dr. Mazal Cohen and Polina Klauzen – Stem cell differentiation specialists
The iPSC Differentiation Center is located at the George S. Wise Faculty of Life Sciences, Britannia Building, Room 117 at Tel Aviv University.
How it works?
Our center employs cutting-edge technologies to optimize differentiation protocols across multiple lineages, including neural, hematopoietic, hepatic, and immune cells. We utilize organoid systems as well as advanced 2D tissue growing techniques to enhance efficiency, scalability, and functional maturity. Our streamlined workflow includes:
-
Standardized Protocol Development – Refining and optimizing differentiation techniques to ensure reproducibility across labs.
-
Multi-Tissue Differentiation – Customizing protocols for diverse cell types to meet research and clinical needs.
-
Advanced Characterization – Employing state-of-the-art imaging, functional assays, and genomic analysis consultation to validate cell maturity and functionality.
-
Collaborative Research – Partnering with academia to push the boundaries of iPSC applications.
Meet The Team
Meet The Board
The Drimmer-Fischler Family and Our Mission
The iPSC Differentiation Center operates within the Drimmer-Fischler Family Stem Cell Core Laboratory for Regenerative Medicine, a leading facility established through the generous support of the Drimmer-Fischler family. Their philanthropic vision has played a pivotal role in advancing stem cell research, fostering innovation, and accelerating the development of groundbreaking therapies.
​
The Drimmer-Fischler family has long been committed to supporting scientific excellence in regenerative medicine, recognizing the transformative potential of iPSC technology. Their contributions have enabled the creation of state-of-the-art infrastructure, cutting-edge research programs, and collaborative projects that drive meaningful advancements in disease modeling, personalized medicine, and therapeutic development.
